Current treatment strategies for multiple sclerosis - efficacy versus neurological adverse effects

Martin S. Weber, Til Menge, Klaus Lehmann-Horn, Helena C. Kronsbein, Uwe Zettl, Johann Sellner, Bernhard Hemmer, Olaf Stüve

Research output: Contribution to journalReview articlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Current treatment strategies for multiple sclerosis - efficacy versus neurological adverse effects'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds